Wall Street major HSBC initiated coverage on Manipal Health with a Buy rating and a target price of Rs 1,000, implying an upside of 26% from current market levels, citing multiple growth levers ahead.
Analysts say Manipal Health, India’s largest private hospital operator, is set to sharpen its focus on profitability after doubling its bed capacity since FY23. The brokerage expects PAT to grow nearly threefold between FY26 and FY29E, while net debt-to-EBITDA is expected to improve to 0.7x in FY27E from 3.7x in FY26.
